New Global Classification for Brain Tumors: ABTA Educational Webinar Series

Brain tumors have been traditionally classified by pathologists mainly based on their histologic appearance under the microscope. While this tried-and-true method is still extremely important for the identification and classification of brain tumors, in some cases, genetic testing of the tumor can more precisely classify the tumor based on important molecular markers.

Recently, the World Health Organization updated its guidelines for brain tumor classification. This update included molecular features to help define and diagnosis brain tumors.

Here from Kenneth Aldape, MD, Professor, Department of Pathology at University of Toronto, where he discusses the importance of this global change for brain tumor classification and provides information on how molecular markers have been incorporated into tumor classification. He also presents how this may help move the field forward for improved diagnosis and treatment of brain tumors.

In this webinar, participants had the opportunity to ask Dr. Aldape questions in an interactive session. Hear his answers and understand the importance of this major milestones for diagnosing and treating brain tumors.

For more information about the ABTA's Educational Webinar and to sign up for other upcoming topics visit: http://www.abta.org/brain-tumor-information/webinars.html.

To view the full collection of ABTA's educational webinars, visit https://www.youtube.com/playlist?list=PLTcHii7RGP5jq-8WyvIBQ8ECjcflTTBCl or the ABTA's Anytime Learning Resource at: http://www.abta.org/brain-tumor-information/anytime-learning/

Видео New Global Classification for Brain Tumors: ABTA Educational Webinar Series канала American Brain Tumor Association